Author

Jordan C. Chervin

Weill Cornell MedicineORCID 0000-0002-8596-3740Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Atsuhiro YasuharaiD· 1 shared Chloe A. TroxelliD· 1 shared Ian A. WilsoniD· 1 shared Jiayi SuniD· 1 shared Lei LiiD· 1 shared Meng YuaniD· 1 shared Min Huang· 1 shared Nai‐Ying ZhengiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Atsuhiro YasuharaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

In Vivo Evolution of Monoclonal Antibody CR3022 to Achieve Cross-Neutralization of SARS-CoV-2 and Implications for Vaccine Strategies Against SARS-Related Viruses

Yanbin Fu, Ziqi Feng, Steven A. Erickson, Peter Halfmann, Lei Li, Jordan C. Chervin, Chloe A. Troxell, Jiayi Sun, Atsuhiro Yasuhara, Siriruk Changrob, Min Huang, Nai‐Ying Zheng, Meng Yuan, Yoshihiro Kawaoka, Ian A. Wilson, Patrick C. Wilson

This study shows that CR3022-like antibodies can be evolved in vivo through vaccination to neutralize SARS-CoV-2 and related viruses by enhancing affinity and breadth.

bioRxiv · Aug 5, 2025 · PreprintImmunology